

Audited annual filings, TTM ratios and consensus forward estimates
Wall Street price targets and rating actions
Revenue disaggregation per 10-K filing
Annual filings (FY) with consensus forward estimates (hatched)
728 daily bars · split adjusted
Current price $52.54
Latest analyst grade actions
Daily · Wilder smoothing
Classic floor pivots from 2026-10-23
Computed from daily OHLCV bars
| Indicator | Value | Type | Action |
|---|---|---|---|
| RSI (14) | 49.36 | Oscillator | Neutral |
| Stochastic %K (14, 3, 3) | 48.37 | Oscillator | Neutral |
| Williams %R (14) | -67.93 | Oscillator | Neutral |
| MACD (12, 26, 9) | 0.14 (Hist -0.05) | Oscillator | Sell |
| Average Directional Index (14) | 9.56 (+DI 20.3 / -DI 21.2) | Trend | Neutral |
| EMA 20 | 52.69 | MA | Sell |
| SMA 20 | 52.71 | MA | Sell |
| EMA 50 | 52.26 | MA | Buy |
| SMA 50 | 52.41 | MA | Buy |
| SMA 200 | 48.17 | MA | Strong Buy |
Free float vs. closely held shares
13F institutional holdings are not available in the current data plan.
SEC Form 4 filings
TTM vs. 5-year historical average (annual ratios)
| Metric | CPAI | Historical (5Y) / ref | Status |
|---|---|---|---|
| P/E ratio (TTM) | — | — · sector 20.4x | n/a |
| Forward P/E | — | — | n/a |
| Price / Book | — | — | n/a |
| Price / Sales | — | — | n/a |
| EV / EBITDA | — | — | n/a |
| Return on equity | — | — | n/a |
| Gross margin | — | — | n/a |
| Debt / Equity | — | — | n/a |
| Piotroski / Altman Z | —/9 | Z — | n/a |
Discounted cash flow model
Stock news · updated daily
Counterpoint Quantitative Equity ETF (NYSE: CPAI - Get Free Report) was the target of a large growth in short interest in September. As of September 30th, there was short interest totaling 63,048 shares, a growth of 347.2% from the September 15th total of 14,099 shares. Based on an average daily volume of 70,933 shares, the days-to-cover
I upgrade the Counterpoint Quantitative Equity ETF to a Buy, as I believe its AI-informed strategy should secure outperformance versus IVV into 2027. My analysis shows that CPAI's portfolio has advantages over IVV in terms of earnings resilience and GARP profile, with fairly robust quality, which I expect to support its outperformance. CPAI has delivered outstanding results since inception, sporting an almost 8% annualized active return over December 2023–September 2026 (with IVV selected as a benchmark).
Reported EPS vs. consensus estimate
SEC EDGAR filings · last 12 months
| Form | Filed | Accepted | Document |
|---|---|---|---|
| 497K | Oct 22, 2026 | 2026-10-22 10:26:06 | View |
| CERT | Oct 16, 2026 | 2026-10-16 11:45:29 | View |
| 497 | Oct 14, 2026 | 2026-10-14 14:46:02 | View |
| 497 | Oct 14, 2026 | 2026-10-14 09:56:30 | View |
| 8-A12B | Oct 9, 2026 | 2026-10-09 15:03:37 | View |
| 485BPOS | Oct 9, 2026 | 2026-10-09 14:37:37 | View |
| 24F-2NT | Sep 21, 2026 | 2026-09-21 14:23:16 | View |
| 24F-2NT | Sep 21, 2026 | 2026-09-21 11:38:24 | View |
| 24F-2NT | Sep 18, 2026 | 2026-09-18 13:14:43 | View |
| N-CEN | Sep 11, 2026 | 2026-09-11 16:51:07 | View |
Proxy statement (DEF 14A) disclosures